Latest News on Gilead Sciences
Showing of 0 - 10 from 1 results
Gilead Sciences - Total results - 1
Jan 16, 2015
Gilead to challenge hepatitis C drug patent rejectionAn order by deputy controller of patents and designs Hardev Karar has said Gilead, which sells the drug under the Sovaldi brand in the US, failed to prove that there were enhancement of therapeutic efficacy in the new discovery.